TrialJCO precision oncology2024

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.

Theodore W Laetsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.